glp-1 drugs depression GLP-1 Depression Warning: Weight-Loss Drugs May Carry Suicide Risk

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database | BMC Medicine

22.47

★★★★☆4.8 (126)

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

23.60

★★★★★4.9 (98)

Part 2 of a 3-Part Series; GLP-1 Medications for Weight Loss

24.58

★★★★★5.0 (157)

Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry

25.11

★★★★★4.7 (84)

Can GLP-1 Drugs Prevent Worsening Mental Illness? Perhaps, Study Suggests Patients with a history of depression or anxiety were less likely to see their mental health decline while on GLP-1 medications. The

24.24

★★★★★4.9 (203)

Researchers are investigating whether these medications known as GLP-1 agonists or GLP-1 drugs could treat everything from cancer and brain disease to depression, addiction and endometriosis. 👉 Read the full story: https://theconversation.com/glp-1

28.93

★★★★★5.0 (176)

GLP-1 Drugs Linked to Higher Depression Risk but Lower Mortality, suggests research

24.76

★★★★★4.8 (132)